These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23436506)

  • 1. Oxidative stress regulates the ubiquitin-proteasome system and immunoproteasome functioning in a mouse model of X-adrenoleukodystrophy.
    Launay N; Ruiz M; Fourcade S; Schlüter A; Guilera C; Ferrer I; Knecht E; Pujol A
    Brain; 2013 Mar; 136(Pt 3):891-904. PubMed ID: 23436506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy.
    Fourcade S; López-Erauskin J; Galino J; Duval C; Naudi A; Jove M; Kemp S; Villarroya F; Ferrer I; Pamplona R; Portero-Otin M; Pujol A
    Hum Mol Genet; 2008 Jun; 17(12):1762-73. PubMed ID: 18344354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial dysfunction and oxidative damage cooperatively fuel axonal degeneration in X-linked adrenoleukodystrophy.
    Fourcade S; López-Erauskin J; Ruiz M; Ferrer I; Pujol A
    Biochimie; 2014 Mar; 98():143-9. PubMed ID: 24076127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy.
    Deon M; Wajner M; Sirtori LR; Fitarelli D; Coelho DM; Sitta A; Barschak AG; Ferreira GC; Haeser A; Giugliani R; Vargas CR
    J Neurol Sci; 2006 Sep; 247(2):157-64. PubMed ID: 16750542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox control of the ubiquitin-proteasome system: from molecular mechanisms to functional significance.
    Kriegenburg F; Poulsen EG; Koch A; Krüger E; Hartmann-Petersen R
    Antioxid Redox Signal; 2011 Oct; 15(8):2265-99. PubMed ID: 21314436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of AMP-activated protein kinase in X-linked adrenoleukodystrophy patient-derived fibroblasts and lymphocytes.
    Singh J; Giri S
    Biochem Biophys Res Commun; 2014 Feb; 445(1):126-31. PubMed ID: 24491542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
    McGuinness MC; Zhang HP; Smith KD
    Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant regulation of the GSK-3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy.
    Ranea-Robles P; Launay N; Ruiz M; Calingasan NY; Dumont M; Naudí A; Portero-Otín M; Pamplona R; Ferrer I; Beal MF; Fourcade S; Pujol A
    EMBO Mol Med; 2018 Aug; 10(8):. PubMed ID: 29997171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy.
    Galino J; Ruiz M; Fourcade S; Schlüter A; López-Erauskin J; Guilera C; Jove M; Naudi A; García-Arumí E; Andreu AL; Starkov AA; Pamplona R; Ferrer I; Portero-Otin M; Pujol A
    Antioxid Redox Signal; 2011 Oct; 15(8):2095-107. PubMed ID: 21453200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy.
    López-Erauskin J; Galino J; Bianchi P; Fourcade S; Andreu AL; Ferrer I; Muñoz-Pinedo C; Pujol A
    Brain; 2012 Dec; 135(Pt 12):3584-98. PubMed ID: 23250880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy induction halts axonal degeneration in a mouse model of X-adrenoleukodystrophy.
    Launay N; Aguado C; Fourcade S; Ruiz M; Grau L; Riera J; Guilera C; Giròs M; Ferrer I; Knecht E; Pujol A
    Acta Neuropathol; 2015 Mar; 129(3):399-415. PubMed ID: 25549970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress is induced in female carriers of X-linked adrenoleukodystrophy.
    Deon M; Sitta A; Barschak AG; Coelho DM; Terroso T; Schmitt GO; Wanderley HY; Jardim LB; Giugliani R; Wajner M; Vargas CR
    J Neurol Sci; 2008 Mar; 266(1-2):79-83. PubMed ID: 17915255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress, mitochondrial and proteostasis malfunction in adrenoleukodystrophy: A paradigm for axonal degeneration.
    Fourcade S; Ferrer I; Pujol A
    Free Radic Biol Med; 2015 Nov; 88(Pt A):18-29. PubMed ID: 26073123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: a paradigm for multifactorial neurodegenerative diseases?
    Galea E; Launay N; Portero-Otin M; Ruiz M; Pamplona R; Aubourg P; Ferrer I; Pujol A
    Biochim Biophys Acta; 2012 Sep; 1822(9):1475-88. PubMed ID: 22353463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy.
    López-Erauskin J; Fourcade S; Galino J; Ruiz M; Schlüter A; Naudi A; Jove M; Portero-Otin M; Pamplona R; Ferrer I; Pujol A
    Ann Neurol; 2011 Jul; 70(1):84-92. PubMed ID: 21786300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tauroursodeoxycholic bile acid arrests axonal degeneration by inhibiting the unfolded protein response in X-linked adrenoleukodystrophy.
    Launay N; Ruiz M; Grau L; Ortega FJ; Ilieva EV; Martínez JJ; Galea E; Ferrer I; Knecht E; Pujol A; Fourcade S
    Acta Neuropathol; 2017 Feb; 133(2):283-301. PubMed ID: 28004277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced immunoproteasome formation and accumulation of immunoproteasomal precursors in the brains of lymphocytic choriomeningitis virus-infected mice.
    Kremer M; Henn A; Kolb C; Basler M; Moebius J; Guillaume B; Leist M; Van den Eynde BJ; Groettrup M
    J Immunol; 2010 Nov; 185(9):5549-60. PubMed ID: 20881186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy.
    Morató L; Galino J; Ruiz M; Calingasan NY; Starkov AA; Dumont M; Naudí A; Martínez JJ; Aubourg P; Portero-Otín M; Pamplona R; Galea E; Beal MF; Ferrer I; Fourcade S; Pujol A
    Brain; 2013 Aug; 136(Pt 8):2432-43. PubMed ID: 23794606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of normal cells on ABCD1 deficient cells in vitro and hematopoietic cell transplantation in the X-ALD mouse model.
    Yamada T; Ohyagi Y; Shinnoh N; Kikuchi H; Osoegawa M; Ochi H; Kira J; Furuya H
    J Neurol Sci; 2004 Mar; 218(1-2):91-7. PubMed ID: 14759639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of CYP2E1-dependent oxidant stress on activity of proteasomes in HepG2 cells.
    Kessova IG; Cederbaum AI
    J Pharmacol Exp Ther; 2005 Oct; 315(1):304-12. PubMed ID: 16002458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.